Clustering data with hclust algorithm for (Study ST003737)

Reversed phase NEGATIVE ION MODE (Analysis AN006135)
MetaboliteStructureF1F2F3F4
Hemi-BMP(18:1/18:1)_16:0ME9794790.550.392.160.90
Hemi-BMP(18:1/18:1)_18:1ME9794810.520.361.991.01
Cholesterol sulfateME9794611.081.570.610.74
PA(18:0_20:4)ME9795061.071.280.710.93
PI(20:4/20:4)ME9795450.931.280.960.83
GM3(d34:1)ME9794751.210.891.140.76
PE(P-18:0/20:5)ME9795231.201.010.950.83
PE(P-18:0/22:6)ME9795241.061.120.910.91
Oleic acidME9795021.080.940.861.12
Palmitic acidME9795091.090.890.891.13
BMP(20:4/20:4)ME9794590.971.070.831.13
Palmitoleic acidME9795101.051.050.841.06
PA(16:0_18:1)ME9795041.000.911.170.91
PS(18:0_22:6)ME9795520.940.841.201.01
PI(18:1/18:1)ME9795440.910.901.220.97
PS(18:0_20:4)ME9795510.950.921.180.95
GM3(d36:1)ME9794761.130.901.050.92
LPE(16:0)ME9794921.150.861.010.97
PE(O-16:0/22:6)ME9795130.910.981.031.08
PA(18:1/18:1)ME9795081.020.901.051.04
PG(16:0_18:1)ME9795301.030.891.100.98
PE(O-18:0/22:6)ME9795150.930.881.071.11
PS(18:1/18:1)ME9795530.960.931.071.04
CL(72:6/18:2)ME9794630.930.921.091.05
PG(18:1/18:1)ME9795360.920.911.101.08
BMP(18:1/18:1)ME9794580.940.881.131.04
PS(18:0_18:1)ME9795500.950.921.140.99
PE(O-18:0/20:4)ME9795140.950.941.101.01
PS(16:0_18:1)ME9795470.940.921.121.03
PA(18:0_22:6)ME9795070.941.060.971.03
PE(P-18:1/22:6)ME9795260.951.071.010.97
GM3(d18:1/18:0(d5))ME9794741.020.990.931.06
Arachidonic acid-d8ME9794481.000.951.001.04
PI(18:0_20:4)ME9795420.980.981.001.04
CL(74:9/18:2)ME9794671.010.951.031.01
(3-O-sulfo)GalCer(d18:1/18:0(d3))ME9794400.970.971.051.01
PE(O-16:0/20:4)ME9795120.970.961.061.01
PE(P-18:0/18:1)ME9795200.990.981.031.00
CL(72:8/18:2)ME9794660.990.971.031.02
PE(P-16:0/22:6)ME9795190.990.971.031.02
PS(15:0/18:1(d7))ME9795460.990.961.041.01
CL(72:7/18:2)ME9794640.980.961.041.02
PE(P-16:0/22:4)ME9795180.980.951.041.02
PE(P-16:0/20:4)ME9795161.010.971.040.98
LPE(18:1(d7))ME9794941.030.971.000.99
PE(15:0/18:1(d7))ME9795111.030.981.010.98
Arachidonic acid-d8_MRMME9794491.000.971.011.02
Hemi-BMP(14:0/14:0)_14:0ME9794781.020.971.001.01
PE(P-18:0/18:2)ME9795211.020.971.011.00
BMP(14:0/14:0)ME9794501.010.981.011.00
PG(15:0/18:1(d7))ME9795291.010.971.011.00
PE(P-18:1/20:4)ME9795251.021.011.010.96
PA(15:0/18:1(d7))ME9795031.050.990.980.98
PI(15:0/18:1(d7))ME9795371.031.010.980.97
CL(14:0/14:0/14:0/14:0)ME9794621.041.011.030.92
PE(P-16:0/20:5)ME9795171.070.981.020.93
PE(P-18:0/20:4)ME9795221.090.991.000.92
LPG(16:0)ME9794950.610.691.701.07
LPG(18:1)ME9794970.670.711.351.27
BMP(16:1/16:1)ME9794540.750.611.401.23
BMP(18:0_18:1)ME9794550.770.641.431.16
PG(16:0_22:6)ME9795320.750.631.461.16
BMP(16:0_20:4)ME9794520.790.751.291.17
PG(18:0_22:6)ME9795350.810.881.241.07
PI(16:0_20:4)ME9795390.910.781.271.04
PI(16:0_18:1)ME9795380.870.801.321.00
PI(18:0_22:6)ME9795430.840.811.291.06
LPE(18:0)ME9794930.810.641.511.04
LPI(18:0)ME9795010.760.571.591.07
PI(18:0_18:1)ME9795410.810.721.510.96
PS(16:0_20:4)ME9795480.870.711.460.96
BMP(16:0_18:1)ME9794510.870.691.351.08
PG(18:0_18:1)ME9795330.920.701.381.00
PS(16:0_22:6)ME9795490.970.671.420.95

Factors:

F1genotype:PILRAKO | treatment:LPS
F2genotype:PILRAKO | treatment:Vehicle
F3genotype:WT | treatment:LPS
F4genotype:WT | treatment:Vehicle
Data matrix
  logo